Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2018
Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Vivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Nature Communications
|
February 22, 2020
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
The Lancet. Oncology
|
October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Frontiers in Immunology
|
May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
Madeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Michael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Cancer Immunology, Immunotherapy : CII
|
December 27, 2011
Exploiting antitumor immunity to overcome relapse and improve remission duration
Lei L Chen, Xinjian Chen, Haesun Choi, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 7, 2018
Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Vivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.
Cancer Research
|
September 3, 2004
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors
Lei L Chen, Jonathan C Trent, Elsie F Wu, et al.
Nature Communications
|
February 22, 2020
Immuno-genomic landscape of osteosarcoma
Chia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
The Lancet. Oncology
|
October 10, 2017
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A Tawbi, Melissa Burgess, Vanessa Bolejack, et al.
Frontiers in Immunology
|
May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
Madeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Michael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Cancer Immunology, Immunotherapy : CII
|
December 27, 2011
Exploiting antitumor immunity to overcome relapse and improve remission duration
Lei L Chen, Xinjian Chen, Haesun Choi, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Page
of 12